Atypical hemolytc uremic syndrome secondary to SARS – CoV – 2 infection. A case report.

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare entity in the intensive care unit, however, with a characteristic diagnostic triad and a specific treatment that can improve the morbidity and mortality associated with this syndrome.

Below we present the case of a 72-year-old male patient who was admitted to the intensive care unit with diagnosis of SARS-CoV-2 pneumonia, who developed aHUS secondary to this infection throughout his admission. Eculizumab could not be administered due to the sudden evolution towards multiorgan dysfunction syndrome and death.